title: Mid-term results of mitral valve repair for ischemic mitral regurgitation with ETlogix ring: A single-center study.
abstract: BACKGROUND
  Ischemic mitral regurgitation (IMR) is a common complication of coronary artery disease and represents an independent predictor of mortality. In the IMR the pattern of mitral valve annular dilatation is asymmetrical: this can explain the long-term incidence of recurrent mitral regurgitation after surgical annular size reduction with a symmetrical ring. The aim of this study is to analyze early and mid-term results of mitral valve repair (MVR) with the CMA IMR ETlogix ring, specifically developed for the surgical correction of IMR.
  
  
  METHODS
  Retrospectively, we studied 157 consecutive patients who underwent MVR with the CMA ETlogix ring for the treatment of grade ≥2 IMR in our center between June 2006 and December 2012. We reported clinical and echocardiographic early and mid-term results of this surgical technique.
  
  
  RESULTS
  Postoperative 30days mortality was 6.3%. Postoperative echocardiography evaluation at discharge revealed the absence of residual MR in 70%, mild MR in 26.5% and moderate MR in 3.5% of patients respectively. Median echographic follow-up time was 28 (3-84) months: survival rate was 92.1% at 32months; free from mitral valve reoperation rate was 97.5% and grade >2 MR recurrence free survival rate was 96.6%.
  
  
  CONCLUSIONS
  There are a few reports in the literature concerning the mid-term results of IMR surgical correction with CMA Etlogix ring. Our study, taking into account a large series of patients and an important follow-up period, demonstrates the effectiveness of this surgical repair technique reporting a low mid-term incidence of recurrent MR.
authors.affiliation: Department of Cardiovascular Surgery, University Hospital of Saint Etienne, France. Electronic address: campisis@hotmail.com.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Campisi
authors.affiliation: Department of Cardiovascular Surgery, University Hospital of Saint Etienne, France.
authors.forename: Jean F
authors.initials: JF
authors.lastname: Fuzellier
authors.affiliation: Department of Cardiology, University Hospital of Saint Etienne, France.
authors.forename: Benjamain
authors.initials: B
authors.lastname: Haber
authors.affiliation: Department of Cardiovascular Surgery, University Hospital of Saint Etienne, France.
authors.forename: Jean P
authors.initials: JP
authors.lastname: Favre
authors.affiliation: Department of Cardiology, University Hospital of Saint Etienne, France.
authors.forename: Antoine
authors.initials: A
authors.lastname: Gerbay
authors.affiliation: Department of Cardiovascular Surgery, University Hospital of Saint Etienne, France.
authors.forename: Marco
authors.initials: M
authors.lastname: Vola
mesh_terms: D000368:Aged; D017023:Coronary Angiography; D004452:Echocardiography; D005260:Female; D005500:Follow-Up Studies; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008943:Mitral Valve / Q000000981:diagnostic imaging / Q000601:surgery*; D058386:Mitral Valve Annuloplasty / Q000379:methods*; D008944:Mitral Valve Insufficiency / Q000175:diagnosis / Q000209:etiology / Q000601:surgery*; D017202:Myocardial Ischemia / Q000150:complications* / Q000175:diagnosis; D011474:Prosthesis Design; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome
keywords: Ischemic mitral valve regurgitation; Mitral valve repair